Abstract

http://ssrn.com/abstract=1146222
 
 

References (54)



 
 

Citations (20)



 


 



A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration


Andrew Ching


University of Toronto - Rotman School of Management

February 2, 2009

International Economic Review, Vol. 51, No. 4, pp. 1175-1207, November 2010

Abstract:     
Motivated by the slow diffusion of generic drugs and the increase in prices of brand-name drugs after generic entry, I incorporate consumer learning and consumer heterogeneity into an empirical dynamic oligopoly model. In the model, firms choose prices to maximize their expected total discounted profits. Moreover, generic firms make their entry decisions before patent expiration. The entry time of generics depends on the FDA random approval process. I apply this model to the market of clonidine. The parameters of the model are estimated and calibrated. The model replicates the stylized facts fairly well. I confirm that consumer heterogeneity in price sensitivity plays an important role in explaining the brand-name pricing pattern. I also apply the model to examine the impact of a policy experiment, which shortens the expected approval time for generics. Although this experiment brings generics to the market sooner, it also reduces the number of generic entrants as the likelihood of entering a crowded market in the early periods increases. Given the change in magnitude of the policy parameter, the experiment improves the rate of learning, and lowers the equilibrium generic prices throughout the period. However, it hardly raises the overall welfare.

Number of Pages in PDF File: 57

Keywords: Dynamic Oligopoly, Prescription Drugs, Brand-name Drugs, Generic Drugs, Patent Expiration, Consumer Learning, Consumer Heterogeneity

JEL Classification: C73, D43, D83, L13, L65

Accepted Paper Series


Download This Paper

Date posted: June 16, 2008 ; Last revised: July 31, 2012

Suggested Citation

Ching, Andrew, A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration (February 2, 2009). International Economic Review, Vol. 51, No. 4, pp. 1175-1207, November 2010. Available at SSRN: http://ssrn.com/abstract=1146222

Contact Information

Andrew Ching (Contact Author)
University of Toronto - Rotman School of Management ( email )
105 St. George Street
Toronto, Ontario M5S 3E6
Canada
HOME PAGE: http://www.rotman.utoronto.ca/andrew.ching
Feedback to SSRN


Paper statistics
Abstract Views: 3,242
Downloads: 438
Download Rank: 35,368
References:  54
Citations:  20

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.391 seconds